532523:BOM
Biocon Ltd
350,00 INR
arrow_downward
-0,43%(-1,50) 1 d.
16. 10., 15:30:00 GMT+5:30 · INR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 532523…
Otvoriť
352,95 INR
Vysoká
352,95 INR
Nízka
348,10 INR
Trh. kap.
568,79 mld.
Priem. obj.
692,61 tis.
Objem
668,34 tis.
Dividenda
0,14 %
Štvrťročná dividenda
0,13 INR
Prvý obchodný deň po vyplatení dividendy
3. 7. 2026
Pomer cena/zárobky
103,62
Max. za 52 týž.
447,00 INR
Min. za 52 týž.
337,95 INR
Výnosy na akciu
3,38 INR
Akcie v obehu
600,00 mil.
Počet zamestnancov
16 tis.
Otvoriť
352,95 INR
Vysoká
352,95 INR
Nízka
348,10 INR
Trh. kap.
568,79 mld.
Priem. obj.
692,61 tis.
Objem
668,34 tis.
Dividenda
0,14 %
Štvrťročná dividenda
0,13 INR
Prvý obchodný deň po vyplatení dividendy
3. 7. 2026
Pomer cena/zárobky
103,62
Max. za 52 týž.
447,00 INR
Min. za 52 týž.
337,95 INR
Výnosy na akciu
3,38 INR
Akcie v obehu
600,00 mil.
Počet zamestnancov
16 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Simply Wall Street
·
pred 7 minútami
Have Insiders Sold AirJoule Technologies Shares Recently?
MarketWatch
·
pred 22 minútami
Opinion: There is a silent market rotation inside the S&P 500 that’s warning of more weakness ahead
Seeking Alpha
·
pred 52 minútami
This Market Is Rotten Under The Hood - I'm Making These 3 Moves
Yahoo Finance
·
pred 1 dňom
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Informácie o subjekte Biocon Ltd
Generálny riaditeľShreehas P Tambe
Zamestnanci16,4 tis.
Dátum založenia29. 11. 1978
Hlavné sídloBangalúr, Karnátaka, India
Odvetvie-
Webbiocon.com